Thyroid function | Prechemotherapy (n=180) | Postchemotherapy (n=180) | pvalue |
---|---|---|---|
T3 (ng/ml) | 1.16±0.27 | 0.80±0.27 | <0.001 |
T4 (μg/dl) | 7.30±1.23 | 6.87±1.57 | <0.001 |
FT3 (pg/ml) | 2.89±0.57 | 2.10±0.49 | <0.001 |
FT4 (ng/dl) | 0.85±0.14 | 0.90±0.19 | 0.019 |
TSH (μIU/ml) | 2.78±2.16 | 1.00±1.31 | <0.001 |
Age (y) | 49.8 | ||
Clinicopathological features | Number | ||
Tumor size | T0 (impalpable) | 7 | |
 | T1 (≤2 cm) | 66 | |
 | T2 (>2 cm, ≤5 cm) | 90 | |
 | T3 (>5 cm) | 12 | |
 | Unknown | 5 | |
Tumor grade | I | 8 | |
 | II | 150 | |
 | III | 13 | |
 | Unknown | 9 | |
Clinical stage | 0 | 9 | |
 | I | 46 | |
 | II | 107 | |
 | III | 7 | |
 | IV | 5 | |
 | Unknown | 6 | |
Chemotherapy regimens | TEC | 158 | |
 | CEF | 13 | |
 | NP | 8 | |
 | Unknown | 1 |